Lake Street Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2.5
Lake Street analyst Frank Takkinen initiates coverage on Envoy Medical (NASDAQ:COCH) with a Buy rating and announces Price Target of $2.5.
Share
Why It Matters
A Wall Street analyst started following Envoy Medical and says it looks like a good buy. When smart investors first study a company, it can signal they see something interesting there.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.